Vifor (International) Ltd

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 2 securities · may seek to influence control
Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) 13D/A TVRD · 140755307	TVRD	140755307	2.2%	205,465	13D/A	4/16/2025 Event 4/15/2025
Vifor (International) Ltd.			2.2%	205,465
CSL Limited			2.2%	205,465
Cara Therapeutics, Inc. 13D/A CARA · 140755109 Amended under CUSIP 140755307 on 4/16/2025	CARA	140755109	13.5%	7,396,770	13D/A	12/18/2024 Event 12/17/2024
Vifor (International) Ltd.			13.5%	7,396,770
CSL Limited			13.5%	7,396,770

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.